Cardio-renal outcomes with long-term agalsidase alfa enzyme replacement therapy: A 10-year fabry outcome survey (FOS) analysis

FOS Study Group

Research output: Contribution to journal › Article › peer-review

37 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Cardio-renal outcomes with long-term agalsidase alfa enzyme replacement therapy: A 10-year fabry outcome survey (FOS) analysis'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds